TAUNS Laboratories, Inc.
197A.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | ¥58,192,955 | ¥54,902,516 | ¥50,871,892 | ¥63,150,048 |
| - Cash | ¥4,609,929 | ¥9,266,630 | ¥8,580,850 | ¥7,573,438 |
| + Debt | ¥19,509,103 | ¥14,424,000 | ¥13,632,000 | ¥13,315,000 |
| Enterprise Value | ¥73,092,129 | ¥60,059,886 | ¥55,923,042 | ¥68,891,610 |
| Revenue | ¥2,368,410 | ¥1,020,074 | ¥5,626,894 | ¥5,561,397 |
| % Growth | 132.2% | -81.9% | 1.2% | – |
| Gross Profit | ¥1,630,007 | ¥89,796 | ¥3,964,298 | ¥3,910,077 |
| % Margin | 68.8% | 8.8% | 70.5% | 70.3% |
| EBITDA | ¥739,374 | -¥875,684 | ¥2,985,684 | ¥2,967,170 |
| % Margin | 31.2% | -85.8% | 53.1% | 53.4% |
| Net Income | ¥357,902 | -¥330,092 | ¥1,958,624 | ¥1,990,189 |
| % Margin | 15.1% | -32.4% | 34.8% | 35.8% |
| EPS Diluted | 3.33 | -3.05 | 17.94 | 18.55 |
| % Growth | 209.2% | -117% | -3.3% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |